AD-1211
http://dbpedia.org/resource/AD-1211 an entity of type: Thing
AD-1211 is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-prenyl-piperazine derivative, which is structurally unrelated to most other opioid drugs. The (S)-enantiomers in this series are more active as opioid agonists, but the less active (R)-enantiomer of this compound, AD-1211, is a mixed agonist–antagonist at opioid receptors with a similar pharmacological profile to pentazocine, and has atypical opioid effects with little development of tolerance or dependence seen after extended administration in animal studies.
rdf:langString
rdf:langString
AD-1211
xsd:integer
31291508
xsd:integer
1082989884
rdf:langString
none
xsd:integer
23
xsd:integer
83374
xsd:integer
61311
xsd:integer
26286944
xsd:integer
30
xsd:integer
1
xsd:integer
2
xsd:integer
1
xsd:integer
173526
rdf:langString
c1ccccc1CCNCCN2C\C=C/C
xsd:integer
1
rdf:langString
WLHCNEPBQJOHKW-HSZRJFAPSA-N
rdf:langString
AD-1211
xsd:integer
7
xsd:integer
462651127
xsd:integer
200
rdf:langString
AD-1211 is an opioid analgesic drug invented in the 1970s by Dainippon Pharmaceutical Co. It is chemically a 1-substituted-4-prenyl-piperazine derivative, which is structurally unrelated to most other opioid drugs. The (S)-enantiomers in this series are more active as opioid agonists, but the less active (R)-enantiomer of this compound, AD-1211, is a mixed agonist–antagonist at opioid receptors with a similar pharmacological profile to pentazocine, and has atypical opioid effects with little development of tolerance or dependence seen after extended administration in animal studies.
xsd:nonNegativeInteger
3896
xsd:string
61311-01-1 (R)-enantiomer
xsd:string
83374-58-7
xsd:string
7YT87DVF55
xsd:string
173526